Literature DB >> 31691893

Surgical indications for pituitary tumors during pregnancy: a literature review.

Thomas Graillon1,2, Thomas Cuny3,4, Frédéric Castinetti3,4, Blandine Courbière5, Marie Cousin6, Frédérique Albarel4, Isabelle Morange4, Nicolas Bruder7, Thierry Brue3,4, Henry Dufour8,3.   

Abstract

PURPOSE: Surgical indications for pituitary tumors during pregnancy are rare, and are derived from a balance between expected benefits, particularly for maternal benefits, and anesthetic/surgical risks.
METHODS: A literature review was performed to define the optimal surgical indications for pituitary adenomas (PA) and other pituitary tumors during pregnancy.
RESULTS: Main benefits are expected in case of critical visual impairment and/or life-threatening endocrine disturbances. Multidisciplinary patient management is systematically required although nonobstetric surgery presents a reasonable risk during pregnancy. The risks of congenital malformation during the first trimester and those of premature birth during the third trimester make the second trimester the optimal period for surgery. In prolactin-secreting, nonsecreting, GH- and TSH-secreting PAs, transsphenoidal surgery (TS) is recommended in cases involving severe visual impairment, characterized by severe visual field deficit, visual acuity impairment, and abnormal optical coherence tomography findings, and when no other medical alternatives are possible and/or sufficient. Uncontrolled and severe Cushing's disease (CD) during pregnancy increases both maternal and fetal morbimortality, thus justifying TS or sometimes dopamine agonist therapy as a safer alternative. Finally, metyrapone, ketoconazole, or bilateral adrenalectomy could be recommended in certain cases after the failure of medical therapies and/or TS. Surgery is also required for suprasellar meningiomas, craniopharyngiomas, and pituitary cysts in the case of severe visual deficit.
CONCLUSION: Surgical indications for pituitary tumors are rare during pregnancy; therefore, surgery should be avoided when possible. Further, the second trimester should be considered as the optimal surgical period. Severe visual disturbance and uncontrolled CD are the main surgical indications during pregnancy.

Entities:  

Keywords:  Craniopharyngioma; Meningioma; Pituitary adenoma; Pituitary cyst; Pregnancy; Surgery

Year:  2020        PMID: 31691893     DOI: 10.1007/s11102-019-01004-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  80 in total

1.  Ganglion Cell Complex Loss in Chiasmal Compression by Brain Tumors.

Authors:  Marisa G Tieger; Thomas R Hedges; Joseph Ho; Natalie K Erlich-Malona; Laurel N Vuong; Geetha K Athappilly; Carlos E Mendoza-Santiesteban
Journal:  J Neuroophthalmol       Date:  2017-03       Impact factor: 3.042

Review 2.  Cushing syndrome in pregnancy.

Authors:  M A Buescher; H D McClamrock; E Y Adashi
Journal:  Obstet Gynecol       Date:  1992-01       Impact factor: 7.661

Review 3.  Lasting impact of general anaesthesia on the brain: mechanisms and relevance.

Authors:  Laszlo Vutskits; Zhongcong Xie
Journal:  Nat Rev Neurosci       Date:  2016-10-18       Impact factor: 34.870

4.  Cabergoline treatment for recurrent Cushing's disease during pregnancy.

Authors:  Afif Nakhleh; Leonard Saiegh; Maria Reut; Mohammad Sheikh Ahmad; Irit Wirsansky Pearl; Carmela Shechner
Journal:  Hormones (Athens)       Date:  2016-07       Impact factor: 2.885

5.  Bilateral inferior petrosal sinus corticotropin sampling with corticotropin-releasing hormone stimulation in a pregnant patient with Cushing's syndrome.

Authors:  M G Pinette; Y Q Pan; D Oppenheim; S G Pinette; J Blackstone
Journal:  Am J Obstet Gynecol       Date:  1994-08       Impact factor: 8.661

6.  Dopamine D1, dopamine D2, and prolactin receptor messenger ribonucleic acid expression by the polymerase chain reaction in human meningiomas.

Authors:  R S Carroll; U M Schrell; J Zhang; K Dashner; P Nomikos; R Fahlbusch; P M Black
Journal:  Neurosurgery       Date:  1996-02       Impact factor: 4.654

7.  Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

Review 8.  Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma.

Authors:  Mark E Molitch
Journal:  Eur J Endocrinol       Date:  2015-05       Impact factor: 6.664

Review 9.  Prolactinoma and pregnancy: From the wish of conception to lactation.

Authors:  Dominique Maiter
Journal:  Ann Endocrinol (Paris)       Date:  2016-04-26       Impact factor: 2.478

Review 10.  The teratogenic risk.

Authors:  H Tuchmann-Duplessis
Journal:  Am J Ind Med       Date:  1983       Impact factor: 2.214

View more
  3 in total

Review 1.  Meningiomas in Gynecology and Reproduction: an Updated Overview for Clinical Practice.

Authors:  Serena Girardelli; Luigi Albano; Giorgia Mangili; Luca Valsecchi; Emanuela Rabaiotti; Paolo Ivo Cavoretto; Pietro Mortini; Massimo Candiani
Journal:  Reprod Sci       Date:  2021-05-10       Impact factor: 2.924

2.  Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.

Authors:  Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Claudia Battista; Alessandro Bozzao; Marco Caputo; Enrica Ciccarelli; Laura De Marinis; Ernesto De Menis; Marco Faustini Fustini; Franco Grimaldi; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Marco Losa; Pietro Maffei; Davide Milani; Maurizio Poggi; Michele Zini; Laurence Katznelson; Anton Luger; Catalina Poiana
Journal:  Eur J Endocrinol       Date:  2022-02-03       Impact factor: 6.664

Review 3.  The diagnosis and management of Cushing's syndrome in pregnancy.

Authors:  Ross Hamblin; Amy Coulden; Athanasios Fountas; Niki Karavitaki
Journal:  J Neuroendocrinol       Date:  2022-05-01       Impact factor: 3.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.